The association of PD-L1 expression status and the PD-1/PD-L1 inhibitor-related toxicity profile in non-small cell lung cancer
Abstract Objective While PD-L1 expression serves as a predictive biomarker for programmed cell death 1 and its ligand (PD-1/PD-L1) inhibitor efficacy in patients with non-small cell lung cancer (NSCLC), its association with treatment-related adverse events (TRAEs) has yet to be fully elucidated. Thi...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-04-01
|
| Schriftenreihe: | BMC Cancer |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12885-025-14218-5 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
